Clinical Trials Logo
  1. Home
  2. Articular Cartilage Defect
  3. NCT05942430

Autologous Costal Osteochondral Transplantation for Talar Osteochondral Lesions

Articular Cartilage Defect Clinical Trial

Official title:
Evaluation of the Effectiveness and Safety of Autologous Costal Osteochondral Transplantation in the Treatment of Talar Osteochondral Lesions: a Randomized Controlled Clinical Trial

Clinical Trial Summary

The goal of this clinical trial is to evaluate the effectiveness and safety of autologous costal osteochondral transplantation in the treatment of Hepple Stage V talar osteochondral lesions, compared with autologous osteoperiosteal transplantation. The main question it aims to answer is: • Whether autologous costal osteochondral transplantation can achieve better clinical outcomes and cartilage repair quality with lower donor site morbidity than autologous osteoperiosteal transplantation in the treatment of Hepple Stage V talar osteochondral lesions. Participants will be randomly assigned to the intervention group (undergoing autologous costal osteochondral transplantation) or the control group (undergoing autologous osteoperiosteal transplantation). Both groups of participants will receive the same postoperative rehabilitation process and follow-up evaluation.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05942430
Study type Interventional
Source The Third Affiliated Hospital of Southern Medical University
Contact Hao Guo, MD
Phone +8617612003968
Email 416363977@qq.com
Status Recruiting
Phase N/A
Start date September 1, 2023
Completion date February 2028
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT04840147 - A Comparison of JointRep® and Microfracture in Repair of Cartilage Lesions on the Femoral Condyle or Trochlea, N/A
Recruiting NCT04296487 - Introduction of ACI for Cartilage Repair N/A
Recruiting NCT04744402 - Phase 2 Clinical Trial of CartiLife® in the United States Phase 2
Recruiting NCT03588975 - A Study of MACI in Patients Aged 10 to 17 Years With Symptomatic Chondral or Osteochondral Defects of the Knee Phase 3
Recruiting NCT03219307 - NOVOCART 3D Treatment Following Microfracture Failure Phase 3
Active, not recruiting NCT05051332 - Phase 3 Clinical Trial of CartiLife® in Korea Phase 3
Recruiting NCT05402072 - AMIC Compared With Microfracture for Focal Articular Cartilage Damage of the Hip Phase 1
Not yet recruiting NCT05651997 - Study Comparing Two Methods for the Treatment of Large Chondral and Osteochondral Defects of the Knee N/A
Completed NCT00719576 - Superiority of MACI® Versus Microfracture Treatment in Patients With Symptomatic Articular Cartilage Defects in the Knee Phase 3
Not yet recruiting NCT01984450 - A Study to Compare Two Techniques for Articular Cartilage Repair:ACIC Vs. MCIC N/A